Neal Walker is Chief Executive Officer of Aclaris Therapeutics, Inc. (ACRS). The company reported total compensation of $3,375,591 for fiscal year 2025.
| Salary | $615,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $828,426 |
| Option awards | $1,581,615 |
| Non-equity incentive plan | $350,550 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $0 |
| Total | $3,375,591 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Aclaris Therapeutics, Inc. filed April 23, 2026, accession 0001104659-26-047262.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Neal Walker this page | Chief Executive Officer | $3,375,591 |
| Kevin Balthaser | Chief Financial Officer | $1,490,790 |
| James Loerop | Chief Business Officer | $1,447,106 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Aclaris Therapeutics, Inc. compensation brief.
Neal Walker's compensation sits inside Aclaris Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.